Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Improving Therapeutic Options for Patients with Giant Cell Arteritis
Link ID 2291
Title Improving Therapeutic Options for Patients with Giant Cell Arteritis
Url http://www.medscape.com/viewarticle/568451?src=rss
Description The optimal schedule for glucocorticoid therapy is discussed in addition to other treatments that may be used as glucocorticoid-sparing agents.
Current Opinion in Rheumatology
Category Articles > Rheumatology
Keywords
Date Jan 10, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Conversion of Discoid Lupus to Antiphospholipid Syndrome and SLE
  A rare conversion of discoid lupus to antiphospholipid syndrome and systemic lupus erythematosus is presented in a 64-year-old man. What are the related diagnostic and management challenges?
Nature Clinical Practice Rheumatology
Category:   Articles > Rheumatology


2. Characterisation of the Cannabinoid Receptor System in Synovial Tissue and Fluid in Patients With Os
  Pre-clinical and clinical studies have demonstrated that cannabis-based drugs have therapeutic potential in inflammatory diseases, including rheumatoid arthritis and multiple sclerosis.
Arthritis Research & Therapy
Category:   Articles > Rheumatology


3. High BMI Linked to Better Outcome in Patients With Anti-CCP Positive Rheumatoid Arthritis
  In a cohort study, a high body mass index was associated with a less severe disease outcome in patients with rheumatoid arthritis who test positive for anticyclic citrullinated peptide antibodies. Medscape Medical News
Category:   Articles > Rheumatology


4. Risk Factors for Cardiovascular Complications Following Total Joint Replacement Surgery
  High Risk of Cardiovascular Complications Found for Arthritis Patients
ARTHRITIS & RHEUMATISM Research News Alerts
Category:   Articles > Rheumatology


5. Tocilizumab: The First Interleukin-6-Receptor Inhibitor
  Tocilizumab, a novel IL-6R inhibitor, may be beneficial for the treatment of RA in patients who do not respond to methotrexate or disease-modifying antirheumatic drugs.
American Journal of Health-System Pharmacy
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS